AL
TERN

Arnhold LLC’s Terns Pharmaceuticals TERN Stock Holding History

Arnhold LLC’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-162,444
Closed -$8.56M – 119
2026
Q1 		$8.56M Buy
+162,444
New +$6.67M 0.63% 39

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arnhold LLC's TERN Position: Q2 2026 in Review

Arnhold LLC sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 162,444 shares — an estimated $8.56M sold.

Arnhold LLC first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $8.56M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Arnhold LLC reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Arnhold LLC sold 162,444 Terns Pharmaceuticals shares in Q2 2026, an estimated $8.56M.
  • Arnhold LLC first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Arnhold LLC's Terns Pharmaceuticals position peaked at $8.56M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Arnhold LLC's 13F filing for Q2 2026, filed 27 Jul 2026.